Status:
COMPLETED
Comparison of Ectoin® Containing Eye Drops and Ectoin® Containing Eye Spray With the Eye Spray Tears Again®
Lead Sponsor:
Bitop AG
Conditions:
Eye Manifestations
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study aims to gain knowledge on the duration of symptom relief of environmental disorders of the eye as might be present in allergy sufferers after allergen exposure following application of the ...
Detailed Description
The term disorder describes the general development of physical symptoms without vegetative or morphologically detectable impairment. These disorders cause physical symptoms with different severities...
Eligibility Criteria
Inclusion
- Patients have to meet the following inclusion criteria in order to participate in the study:
- Signed and dated informed consent form
- Male and female patients aged 18 to 75 years
- Patients have to suffer from allergen exposure induced environmental disorder of the eye
Exclusion
- \-
- Non-inclusion criteria
- Contraindications according to the package leaflet/summary of product characteristics
- currently wearing contact lenses
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04021225
Start Date
January 1 2019
End Date
June 28 2019
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Facharzt für HNO-Heilkunde, Allergologie
Aachen, North Rhine-Westphalia, Germany, 52074